HealthcareCinven to invest in health tech firm Regenity BiosciencesRegenity is a portfolio company of Linden Capital Partners.ByIris Dorbian12 February 2026•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsNorth AmericaUKUSWestern EuropeHealthcareBriefs